Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13DFiled 2 days ago

PepGen Inc.: RA CAPITAL MANAGEMENT, L.P. amends Schedule 13D stake filing

Open the sourceReported by SEC EDGAR SCHEDULE 13D, sec.gov, 17 November 2026, by SEC EDGAR SCHEDULE 13D

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

RA Capital Management amended its Schedule 13D filing on PepGen Inc., disclosing a change to its previously reported beneficial ownership stake in the clinical-stage biotech. The filing, submitted under SEC accession number 0001346824-26-000301, updates the investor's position without specifying a revised share count in the headline disclosure. The amendment matters because 13D filings signal activist or influential holder intent, and any shift by a major institutional backer can affect how the market views PepGen's governance and strategic direction. Investors will watch for the detailed filing to confirm the exact size and direction of the stake change and whether it reflects accumulation, dilution from share issuance, or a reduction in holdings.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.

Named in this story

PepGen Inc., RA Capital Management, L.P.